About Dendrite
Dendrite is a company based in Antwerp (Belgium) founded in 1986 was acquired by Cegedim in March 2007. Dendrite has raised $3 million across 1 funding round from investors including Cegedim and Edison Partners. Dendrite operates in a competitive market with competitors including ACTO, IMS Health, Axtria, IntegriChain and SHYFT Analytics, among others.
- Headquarter Antwerp, Belgium
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Dendrite
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Dendrite
Dendrite has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Unspecified round of $3 million completed in September 1991. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Dendrite
Dendrite has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Cegedim and Edison Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of a growth equity firm for adaptive and personalized plans
|
Locked | Locked | Locked | |
|
Digital data flow management services
|
Locked | Locked | Locked |
Investor details for Dendrite
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dendrite
Investment portfolio details for Dendrite
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dendrite
Detailed financials for Dendrite
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dendrite Comparisons
Peer comparison for Dendrite
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dendrite
Dendrite operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ACTO, IMS Health, Axtria, IntegriChain and SHYFT Analytics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI and SaaS-based educational platform for life sciences is provided.
|
|
| Locked | Locked | Locked |
SaaS and AI-based market intelligence is provided for healthcare companies.
|
|
| Locked | Locked | Locked |
Data analytics and AI solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Data management and analytics solutions are offered for life sciences.
|
|
| Locked | Locked | Locked |
CompareNetworks delivers media and platform products in web and mobile formats for science and healthcare manufacturers.
|
Detailed competitors of Dendrite
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dendrite
Complete news archive for Dendrite
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dendrite
Dendrite was founded in 1986 and raised its 1st funding round 5 years after it was founded.
Dendrite is headquartered in Antwerp, Belgium.
Dendrite is a funded company, having raised a total of $3M across 1 funding round to date.
Annual revenue of Dendrite is $40.79K as on Dec 31, 2021.
Dendrite International provides services and software for managing and analyzing sales efforts for the pharmaceutical and other life sciences industries. Solutions cover the pharmaceutical commercialization process and fit into five primary categories, including clinical development, brand marketing, customer management, sales effectiveness, and compliance management. Dendrites sales technology and applications enable sales forces to access product information and physician databases, assess competitors, and catalog client and prospect data. Support services include software implementation, technical and hardware support, and sales force support. It was listed in NASDAQ with the symbol DRTE and was later acquired by Cegedim post which it was closed for public trading.
Dendrite's top competitors include Axtria, ACTO and IntegriChain.
Dendrite has 2 investors. Key investors include Cegedim, and Edison Partners.